ISS STAGE III PLASMA CELL MYELOMA

Clinical trials for ISS STAGE III PLASMA CELL MYELOMA explained in plain language.

Never miss a new study

Get alerted when new ISS STAGE III PLASMA CELL MYELOMA trials appear

Sign up with your email to follow new studies for ISS STAGE III PLASMA CELL MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet finished but already full! 1

Four-Pronged attack on Tough-to-Treat blood cancer

Disease control Ongoing

This study is testing a combination of four chemotherapy drugs to treat a more aggressive form of multiple myeloma, a blood cancer. The main goal is to see if this treatment can make the cancer undetectable in blood tests and keep it that way for at least a year. It is for newly …

Matched conditions: ISS STAGE III PLASMA CELL MYELOMA

Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control

Last updated Mar 25, 2026 14:07 UTC

ISS STAGE III PLASMA CELL MYELOMA

Get alerted when new ISS STAGE III PLASMA CELL MYELOMA trials appear

Four-Pronged attack on Tough-to-Treat blood cancer